Our data do not reveal a significant trend due to the small number of patients and the almost exclusive use of immunotherapy, either compassionate use or simultaneous to radiotherapy.
← all excerpts
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort.
1
—
—